Donald M Lai, MD
Cardiovascular Disease (Cardiology) · Pleasanton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 5
Offices
5 locations · Stanford Health Care · University Healthcare Alliance
Looking this up.
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lai’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G54833 · Current
Licensed to practise in California · since 1985 · expires 2027-01-31 · University of Maryland School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$222,888
Medicare paid this office $222,888 for 1,393 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 472 | $116,945 | $104 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 176 | $29,575 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $9,908 | $104 |
| Long return visit (40+ min) | 49 | $9,864 | $159 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 357 | $8,617 | $15 |
See all 22 services
| Return visit (30+ min) | 472 | $116,945 | $104 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 176 | $29,575 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $9,908 | $104 |
| Long return visit (40+ min) | 49 | $9,864 | $159 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 357 | $8,617 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 759 | $7,626 | $7 |
| Short return visit (20+ min) | 74 | $6,240 | $73 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,280 | $143 |
| Programming of dual lead pacemaker system | 32 | $3,351 | $76 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 26 | $2,325 | $57 |
| New patient visit (45+ min) | 20 | $2,100 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 30 | $1,759 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,528 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 98 | $1,512 | $13 |
| Programming of single lead pacemaker system | 14 | $1,356 | $68 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 59 | $1,281 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 117 | $858 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 22 | $620 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 23 | $413 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 29 | $344 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 22 | $259 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 14 | $197 | $10 |
Who their Medicare patients are
1,393 Original Medicare patients in 2024. Average age 77 · Under 65 6% · 85 and older 22% · Women 52% · Also on Medicaid 24% · Health risk score 1.93. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Chronic kidney disease 46% · Coronary heart disease 45% · Diabetes 38% · Atrial fibrillation 37% · Heart failure 32% · Depression 24% · Cancer 23% · COPD 22% · Dementia 16% · Stroke 15%.
The office billed $1,224,780, Medicare allowed $310,784 and paid $222,888; for 4,051 services of 45 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,393 | 4,051 | 77 | 1.93 | $1,224,780 | $222,888 |
| 2023 | 1,398 | 4,323 | 77 | 1.81 | $1,804,370 | $271,751 |
| 2022 | 1,132 | 3,633 | 78 | 1.79 | $1,424,791 | $249,831 |
| 2021 | 1,079 | 3,566 | 77 | 1.79 | $1,217,901 | $291,502 |
| 2020 | 1,024 | 3,854 | 77 | 1.98 | $1,249,838 | $250,022 |
| 2019 | 1,257 | 4,424 | 77 | 1.89 | $1,449,006 | $302,425 |
| 2018 | 1,135 | 3,794 | 77 | 1.86 | $1,334,217 | $290,362 |
| 2017 | 1,124 | 3,768 | 77 | 1.77 | $1,159,376 | $275,737 |
| 2016 | 1,140 | 3,926 | 77 | 1.90 | $1,221,628 | $298,299 |
| 2015 | 1,141 | 3,858 | 77 | 1.87 | $964,710 | $271,759 |
| 2014 | 1,181 | 3,929 | 77 | 1.77 | $825,437 | $284,428 |
| 2013 | 1,140 | 3,617 | 77 | 1.75 | $722,327 | $255,061 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 26 services
| Return visit (30+ min) | 525 | $147,194 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $24,517 | $105 |
| New patient visit (45+ min) | 87 | $11,883 | $137 |
| Short return visit (20+ min) | 115 | $10,421 | $72 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $10,163 | $147 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 147 | $9,023 | $57 |
| Long return visit (40+ min) | 39 | $7,280 | $158 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 674 | $6,951 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 82 | $4,789 | $58 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 18 | $3,704 | $206 |
| Programming of dual lead pacemaker system | 32 | $3,296 | $75 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 32 | $3,159 | $21 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $3,157 | $70 |
| Telehealth originating site facility fee | 77 | $2,184 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 32 | $1,748 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 105 | $1,651 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 22 | $1,526 | $69 |
| Programming of single lead pacemaker system | 13 | $1,409 | $64 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 58 | $1,310 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 132 | $1,099 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 33 | $409 | $12 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 16 | $368 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 22 | $354 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 30 | $331 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $283 | $19 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 14 | $64 | $5 |
2022: 22 services
| Return visit (30+ min) | 423 | $139,950 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 93 | $18,330 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 114 | $14,677 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $11,741 | $163 |
| New patient visit (45+ min) | 66 | $9,370 | $142 |
| Short return visit (20+ min) | 86 | $8,865 | $69 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 99 | $5,845 | $58 |
| Long return visit (40+ min) | 26 | $5,031 | $168 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 452 | $4,386 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 210 | $3,479 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,800 | $62 |
| Programming of dual lead pacemaker system | 23 | $1,853 | $77 |
| Telehealth originating site facility fee | 50 | $1,179 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 29 | $1,094 | $25 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 40 | $985 | $24 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 24 | $953 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 65 | $866 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 36 | $690 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 87 | $685 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 21 | $517 | $25 |
| Ultrasound of heart | 12 | $471 | $39 |
| Heart rhythm recording of continous external ekg over 8-15 days | 17 | $250 | $15 |
2021: 18 services
| Return visit (30+ min) | 416 | $170,629 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 82 | $26,313 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 118 | $24,568 | $208 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $12,541 | $182 |
| New patient visit (45+ min) | 55 | $9,075 | $165 |
| Short return visit (20+ min) | 99 | $8,273 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 546 | $5,457 | $7 |
| Long return visit (40+ min) | 27 | $5,222 | $163 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 72 | $4,630 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $3,088 | $63 |
| Initial hospital observation care per day, typically 70 minutes | 16 | $2,963 | $174 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 102 | $2,151 | $14 |
| Telephone medical discussion with physician, 11-20 minutes | 25 | $2,083 | $61 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 41 | $873 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 54 | $725 | $13 |
| Heart rhythm recording of continous external ekg over 8-15 days | 36 | $573 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $237 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 26 | $204 | $7 |
2020: 29 services
| Return visit (30+ min) | 354 | $72,614 | $88 |
| Short return visit (20+ min) | 284 | $38,475 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $26,470 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 98 | $20,338 | $208 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $14,291 | $183 |
| Telephone medical discussion with physician, 11-20 minutes | 109 | $11,408 | $69 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 84 | $5,764 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 509 | $4,793 | $7 |
| Initial hospital observation care per day, typically 70 minutes | 22 | $4,774 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $4,441 | $66 |
| New patient visit (45+ min) | 29 | $3,941 | $136 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 38 | $3,744 | $24 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,431 | $229 |
| Long return visit (40+ min) | 18 | $2,764 | $138 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 129 | $2,706 | $16 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 40 | $2,400 | $27 |
| Programming of dual lead pacemaker system | 22 | $2,188 | $64 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 31 | $1,956 | $28 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $1,677 | $99 |
| Follow-up observation care per day, typically 35 minutes | 14 | $1,531 | $102 |
| New patient visit (30+ min) | 13 | $1,264 | $97 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 16 | $1,260 | $79 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 59 | $787 | $13 |
| External ekg recording for more than 48 hours up to 21 days | 21 | $618 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 16 | $397 | $25 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $378 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $291 | $11 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 16 | $207 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 38 | $206 | $5 |
2019: 22 services
| Return visit (30+ min) | 444 | $137,635 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 105 | $34,411 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $19,632 | $172 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 83 | $17,313 | $206 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 188 | $12,277 | $64 |
| New patient visit (45+ min) | 79 | $11,011 | $139 |
| Short return visit (20+ min) | 114 | $8,827 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 571 | $5,684 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $5,509 | $63 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 48 | $4,457 | $91 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $4,168 | $219 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 200 | $4,025 | $16 |
| Long return visit (40+ min) | 29 | $3,570 | $119 |
| Programming of dual lead pacemaker system | 31 | $3,035 | $63 |
| Follow-up observation care per day, typically 35 minutes | 21 | $2,789 | $90 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 25 | $2,745 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 162 | $2,161 | $13 |
| New patient visit (30+ min) | 22 | $2,143 | $97 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 27 | $1,714 | $27 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 21 | $1,363 | $28 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 36 | $447 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 21 | $153 | $7 |
2018: 20 services
| Return visit (30+ min) | 412 | $121,301 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 136 | $24,259 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $22,004 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 104 | $21,424 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 102 | $13,885 | $65 |
| New patient visit (45+ min) | 93 | $12,676 | $136 |
| Short return visit (20+ min) | 153 | $11,289 | $53 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 147 | $9,585 | $63 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $5,361 | $199 |
| Long return visit (40+ min) | 33 | $4,518 | $122 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 43 | $4,206 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 178 | $3,707 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 380 | $3,495 | $7 |
| New patient visit (60+ min) | 14 | $2,086 | $149 |
| New patient visit (30+ min) | 21 | $1,958 | $93 |
| Long return visit (40+ min) | 14 | $1,580 | $99 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 108 | $1,441 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 46 | $914 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 46 | $399 | $8 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $263 | $11 |
2017: 20 services
| Return visit (30+ min) | 416 | $120,281 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 127 | $23,903 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 85 | $19,447 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 107 | $18,785 | $63 |
| New patient visit (45+ min) | 103 | $14,449 | $140 |
| Short return visit (20+ min) | 151 | $12,016 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 167 | $10,600 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 109 | $6,206 | $55 |
| Long return visit (40+ min) | 42 | $5,569 | $121 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 40 | $3,559 | $85 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $3,280 | $182 |
| New patient visit (60+ min) | 23 | $3,223 | $140 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 317 | $3,050 | $7 |
| Programming of dual lead pacemaker system | 27 | $2,056 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 84 | $1,575 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 152 | $1,321 | $7 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 12 | $1,117 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 12 | $747 | $27 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 12 | $589 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $139 | $11 |
2016: 18 services
| Return visit (30+ min) | 427 | $116,775 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 157 | $46,084 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 164 | $32,338 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 85 | $14,384 | $62 |
| New patient visit (45+ min) | 87 | $11,808 | $136 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 167 | $9,362 | $55 |
| Long return visit (40+ min) | 56 | $8,228 | $125 |
| Short return visit (20+ min) | 105 | $6,978 | $51 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 125 | $6,951 | $54 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $6,140 | $212 |
| New patient visit (60+ min) | 21 | $3,665 | $175 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 326 | $3,265 | $7 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,579 | $117 |
| Programming of dual lead pacemaker system | 28 | $2,109 | $45 |
| Initial hospital observation care per day, typically 70 minutes | 12 | $1,912 | $159 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 99 | $1,745 | $15 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 19 | $1,655 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 143 | $1,184 | $7 |
2015: 22 services
| Return visit (30+ min) | 329 | $72,114 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 180 | $38,976 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 184 | $37,594 | $173 |
| Short return visit (20+ min) | 299 | $32,190 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 303 | $17,230 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $15,195 | $89 |
| New patient visit (45+ min) | 77 | $10,483 | $136 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $5,466 | $219 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 430 | $3,936 | $7 |
| Long return visit (40+ min) | 26 | $3,260 | $125 |
| Initial hospital observation care per day, typically 70 minutes | 19 | $2,921 | $154 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 22 | $1,781 | $77 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 95 | $1,720 | $15 |
| Programming of dual lead pacemaker system | 22 | $1,374 | $46 |
| Follow-up observation care per day, typically 35 minutes | 14 | $1,359 | $91 |
| External shock to heart to regulate heart beat | 11 | $1,180 | $107 |
| Return visit (30+ min) | 16 | $1,146 | $67 |
| Follow-up observation care per day, typically 25 minutes | 17 | $1,130 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 19 | $1,107 | $55 |
| New patient visit (30+ min) | 12 | $1,058 | $88 |
| Hospital discharge day management, 30 minutes or less | 12 | $765 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 46 | $359 | $7 |
2014: 19 services
| Return visit (30+ min) | 304 | $67,197 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 222 | $65,490 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 184 | $37,238 | $173 |
| Short return visit (20+ min) | 286 | $31,458 | $57 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 289 | $16,862 | $55 |
| New patient visit (45+ min) | 65 | $9,047 | $139 |
| Initial hospital observation care per day, typically 70 minutes | 41 | $6,682 | $155 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $5,239 | $218 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 515 | $4,922 | $7 |
| Long return visit (40+ min) | 31 | $4,345 | $128 |
| Follow-up observation care per day, typically 35 minutes | 39 | $4,140 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,466 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 103 | $1,872 | $14 |
| Programming of dual lead pacemaker system | 24 | $1,741 | $50 |
| Return visit (30+ min) | 20 | $1,351 | $68 |
| New patient visit (30+ min) | 15 | $1,293 | $86 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 13 | $1,044 | $80 |
| Follow-up observation care per day, typically 25 minutes | 12 | $812 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 21 | $154 | $7 |
2013: 23 services
| Return visit (30+ min) | 303 | $80,763 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 164 | $47,173 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 132 | $25,346 | $169 |
| Short return visit (20+ min) | 234 | $21,555 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 104 | $13,752 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 232 | $12,800 | $53 |
| New patient visit (45+ min) | 43 | $5,885 | $137 |
| Initial hospital observation care per day, typically 70 minutes | 34 | $5,383 | $154 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $4,987 | $208 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 533 | $4,494 | $7 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,439 | $114 |
| Long return visit (40+ min) | 18 | $2,569 | $122 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 26 | $1,693 | $65 |
| New patient visit (30+ min) | 19 | $1,688 | $89 |
| Follow-up observation care per day, typically 35 minutes | 15 | $1,306 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 57 | $1,097 | $16 |
| Programming of dual lead pacemaker system | 14 | $1,032 | $49 |
| Follow-up observation care per day, typically 25 minutes | 15 | $909 | $61 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 11 | $888 | $81 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $375 | $29 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $279 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $185 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $97 | $7 |
Medicaid work
$4,908 in 2024
Medicaid paid $4,908 for 750 billed services this clinician did in 2024, up to 160 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 735 | $4,336 |
| Return visit (30+ min) | 15 | $572 |
| 2024 | 750 | 2 | 160 | $4,908 |
| 2023 | 746 | 3 | 157 | $6,025 |
| 2022 | 401 | 2 | 101 | $2,515 |
| 2021 | 461 | 1 | 60 | $1,827 |
| 2020 | 354 | 1 | 54 | $1,604 |
| 2019 | 413 | 2 | 80 | $2,490 |
| 2018 | 378 | 1 | 69 | $1,726 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 706 | $4,115 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 28 | $1,685 |
| Return visit (30+ min) | 12 | $225 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 368 | $2,048 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 33 | $467 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 461 | $1,827 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 354 | $1,604 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 401 | $1,714 |
| Return visit (30+ min) | 12 | $775 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 378 | $1,726 |
Drugs they prescribed that Part D paid
$1,005,929
Pharmacies billed $1,005,929 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
3,726 generic and 748 brand-name prescriptions · $1,005,929 in drug cost · 13 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 423 | $584,236 | $1,381 |
| Xarelto | 121 | $171,061 | $1,414 |
| Entresto | 69 | $104,983 | $1,521 |
| Jardiance | 22 | $27,008 | $1,228 |
| Farxiga | 15 | $18,825 | $1,255 |
See all 43 drugs
| Eliquis | 423 | $584,236 | $1,381 |
| Xarelto | 121 | $171,061 | $1,414 |
| Entresto | 69 | $104,983 | $1,521 |
| Jardiance | 22 | $27,008 | $1,228 |
| Farxiga | 15 | $18,825 | $1,255 |
| Brilinta | 12 | $13,780 | $1,148 |
| Metoprolol | 399 | $5,457 | $14 |
| Atorvastatin | 575 | $5,076 | $9 |
| Olmesartan Medoxomil | 139 | $3,972 | $29 |
| Rosuvastatin | 223 | $3,815 | $17 |
| Diltiazem 24hr Er (Cd) | 70 | $3,143 | $45 |
| Flecainide Acetate | 52 | $2,926 | $56 |
| Potassium Chloride | 138 | $2,917 | $21 |
| Valsartan | 76 | $1,872 | $25 |
| Carvedilol | 146 | $1,783 | $12 |
| Furosemide | 209 | $1,691 | $8 |
| Losartan | 163 | $1,488 | $9 |
| Bumetanide | 35 | $1,342 | $38 |
| Metoprolol | 148 | $1,306 | $9 |
| Amlodipine Besylate | 210 | $1,198 | $6 |
| Atenolol | 145 | $1,078 | $7 |
| Ezetimibe | 41 | $1,077 | $26 |
| Clopidogrel | 77 | $957 | $12 |
| Lisinopril | 155 | $945 | $6 |
| Digoxin | 31 | $891 | $29 |
| Isosorbide Mononitrate Er | 42 | $621 | $15 |
| Pravastatin | 48 | $609 | $13 |
| Irbesartan | 14 | $566 | $40 |
| Nitroglycerin | 41 | $493 | $12 |
| Hydralazine | 41 | $483 | $12 |
| Hydrochlorothiazide | 93 | $482 | $5 |
| Amiodarone | 36 | $481 | $13 |
| Levothyroxine | 34 | $384 | $11 |
| Warfarin | 41 | $363 | $9 |
| Simvastatin | 41 | $346 | $8 |
| Tamsulosin | 22 | $266 | $12 |
| Pantoprazole | 14 | $223 | $16 |
| Sotalol | 11 | $201 | $18 |
| Finasteride | 14 | $143 | $10 |
| Lisinopril-Hydrochlorothiazide | 11 | $116 | $11 |
| Clonidine | 19 | $113 | $6 |
| Benazepril | 13 | $84 | $6 |
| Metformin | 11 | $84 | $8 |
Year by year
| 2024 | 4,474 | 549 | None | 17% | $1,005,929 |
| 2023 | 4,247 | 595 | 0% (0) | None | $979,990 |
| 2022 | 3,632 | 424 | 0% (0) | 16% | $702,960 |
| 2021 | 3,484 | 417 | 0% (0) | 18% | $662,412 |
| 2020 | 3,483 | 404 | 0% (0) | 19% | $611,129 |
| 2019 | 3,417 | 465 | None | 19% | $517,430 |
| 2018 | 3,073 | 351 | None | 19% | $433,609 |
| 2017 | 2,937 | 322 | 0% (0) | 24% | $363,304 |
| 2016 | 2,821 | 318 | None | None | $311,038 |
| 2015 | 2,762 | 302 | None | None | $213,786 |
| 2014 | 2,478 | 271 | None | 22% | $168,772 |
| 2013 | 2,600 | 262 | None | 22% | $148,655 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 42 drugs
| Eliquis | 363 | $497,966 | $1,372 |
| Xarelto | 156 | $227,812 | $1,460 |
| Entresto | 74 | $107,913 | $1,458 |
| Brilinta | 16 | $13,438 | $840 |
| Praluent | 13 | $8,974 | $690 |
| Atorvastatin | 488 | $8,077 | $17 |
| Metoprolol | 398 | $7,393 | $19 |
| Olmesartan Medoxomil | 141 | $5,631 | $40 |
| Rosuvastatin | 160 | $4,721 | $30 |
| Diltiazem 24hr Er (Cd) | 91 | $4,666 | $51 |
| Potassium Chloride | 120 | $4,461 | $37 |
| Flecainide Acetate | 47 | $3,625 | $77 |
| Ezetimibe | 47 | $3,101 | $66 |
| Valsartan | 66 | $2,527 | $38 |
| Amlodipine Besylate | 243 | $2,326 | $10 |
| Losartan | 150 | $2,259 | $15 |
| Carvedilol | 110 | $2,120 | $19 |
| Metoprolol | 126 | $2,053 | $16 |
| Furosemide | 196 | $1,841 | $9 |
| Atenolol | 178 | $1,701 | $10 |
| Clopidogrel | 89 | $1,546 | $17 |
| Lisinopril | 141 | $1,541 | $11 |
| Bumetanide | 21 | $1,427 | $68 |
| Midodrine | 21 | $1,420 | $68 |
| Warfarin | 52 | $1,233 | $24 |
| Isosorbide Mononitrate Er | 41 | $1,106 | $27 |
| Digoxin | 28 | $710 | $25 |
| Propafenone | 12 | $643 | $54 |
| Levothyroxine | 40 | $613 | $15 |
| Irbesartan | 14 | $607 | $43 |
| Amiodarone | 36 | $602 | $17 |
| Hydralazine | 30 | $575 | $19 |
| Hydrochlorothiazide | 93 | $513 | $6 |
| Simvastatin | 35 | $453 | $13 |
| Nitroglycerin | 34 | $434 | $13 |
| Tamsulosin | 24 | $399 | $17 |
| Propranolol | 16 | $389 | $24 |
| Pravastatin | 30 | $349 | $12 |
| Clonidine | 28 | $215 | $8 |
| Pantoprazole | 13 | $156 | $12 |
| Triamterene-Hydrochlorothiazid | 13 | $78 | $6 |
| Benazepril | 13 | $65 | $5 |
2022: 43 drugs
| Eliquis | 240 | $298,256 | $1,243 |
| Xarelto | 151 | $212,541 | $1,408 |
| Entresto | 45 | $60,922 | $1,354 |
| Januvia | 13 | $8,320 | $640 |
| Praluent | 12 | $6,068 | $506 |
| Atorvastatin | 426 | $5,695 | $13 |
| Metoprolol | 308 | $5,150 | $17 |
| Olmesartan Medoxomil | 134 | $4,171 | $31 |
| Flecainide Acetate | 45 | $4,095 | $91 |
| Potassium Chloride | 136 | $3,930 | $29 |
| Valsartan | 85 | $3,911 | $46 |
| Rosuvastatin | 104 | $3,490 | $34 |
| Diltiazem 24hr Er (Cd) | 56 | $2,919 | $52 |
| Ezetimibe | 29 | $2,464 | $85 |
| Losartan | 149 | $1,825 | $12 |
| Amiodarone | 37 | $1,782 | $48 |
| Atenolol | 160 | $1,613 | $10 |
| Furosemide | 182 | $1,525 | $8 |
| Amlodipine Besylate | 215 | $1,492 | $7 |
| Clopidogrel | 79 | $1,398 | $18 |
| Carvedilol | 91 | $1,345 | $15 |
| Propafenone | 21 | $1,169 | $56 |
| Irbesartan | 15 | $1,114 | $74 |
| Metoprolol | 113 | $1,097 | $10 |
| Warfarin | 57 | $1,065 | $19 |
| Lisinopril | 116 | $958 | $8 |
| Isosorbide Mononitrate Er | 40 | $935 | $23 |
| Midodrine | 12 | $844 | $70 |
| Dilt-Xr | 21 | $698 | $33 |
| Levothyroxine | 24 | $609 | $25 |
| Digoxin | 16 | $571 | $36 |
| Tamsulosin | 17 | $512 | $30 |
| Hydrochlorothiazide | 95 | $446 | $5 |
| Diltiazem 24hr Er | 14 | $419 | $30 |
| Nitroglycerin | 35 | $403 | $12 |
| Simvastatin | 36 | $374 | $10 |
| Pravastatin | 16 | $369 | $23 |
| Klor-Con 10 | 12 | $259 | $22 |
| Pantoprazole | 18 | $254 | $14 |
| Triamterene-Hydrochlorothiazid | 15 | $167 | $11 |
| Clonidine | 27 | $150 | $6 |
| Hydralazine | 11 | $101 | $9 |
| Lorazepam | 11 | $25 | $2 |
2021: 44 drugs
| Xarelto | 210 | $263,444 | $1,254 |
| Eliquis | 189 | $221,115 | $1,170 |
| Entresto | 40 | $49,331 | $1,233 |
| Brilinta | 18 | $17,702 | $983 |
| Multaq | 14 | $11,594 | $828 |
| Atorvastatin | 419 | $6,974 | $17 |
| Metoprolol | 281 | $5,484 | $20 |
| Olmesartan Medoxomil | 81 | $4,342 | $54 |
| Flecainide Acetate | 52 | $3,970 | $76 |
| Potassium Chloride | 103 | $3,346 | $32 |
| Diltiazem 24hr Er (Cd) | 57 | $2,879 | $51 |
| Rosuvastatin | 87 | $2,856 | $33 |
| Losartan | 196 | $2,809 | $14 |
| Valsartan | 45 | $1,961 | $44 |
| Ezetimibe | 26 | $1,804 | $69 |
| Atenolol | 147 | $1,768 | $12 |
| Furosemide | 196 | $1,709 | $9 |
| Carvedilol | 104 | $1,617 | $16 |
| Lisinopril | 120 | $1,430 | $12 |
| Clopidogrel | 67 | $1,398 | $21 |
| Dilt-Xr | 29 | $1,294 | $45 |
| Irbesartan | 17 | $1,262 | $74 |
| Metoprolol | 120 | $1,256 | $10 |
| Amiodarone | 31 | $1,252 | $40 |
| Amlodipine Besylate | 160 | $1,232 | $8 |
| Diltiazem 24hr Er | 26 | $1,210 | $47 |
| Warfarin | 60 | $1,089 | $18 |
| Propafenone | 21 | $1,026 | $49 |
| Levothyroxine | 33 | $908 | $28 |
| Isosorbide Mononitrate Er | 44 | $897 | $20 |
| Nitroglycerin | 50 | $820 | $16 |
| Cartia Xt | 12 | $733 | $61 |
| Digoxin | 15 | $662 | $44 |
| Pantoprazole | 22 | $523 | $24 |
| Clonidine | 20 | $356 | $18 |
| Pravastatin | 16 | $354 | $22 |
| Tamsulosin | 16 | $350 | $22 |
| Hydrochlorothiazide | 70 | $335 | $5 |
| Hydralazine | 12 | $301 | $25 |
| Simvastatin | 21 | $216 | $10 |
| Triamterene-Hydrochlorothiazid | 17 | $199 | $12 |
| Metformin | 11 | $107 | $10 |
| Spironolactone | 11 | $64 | $6 |
| Lorazepam | 15 | $45 | $3 |
2020: 45 drugs
| Xarelto | 224 | $255,943 | $1,143 |
| Eliquis | 148 | $168,460 | $1,138 |
| Entresto | 58 | $57,228 | $987 |
| Multaq | 16 | $16,134 | $1,008 |
| Brilinta | 19 | $11,741 | $618 |
| Atorvastatin | 404 | $7,670 | $19 |
| Metoprolol | 248 | $6,464 | $26 |
| Livalo | 12 | $6,444 | $537 |
| Ezetimibe | 28 | $3,504 | $125 |
| Losartan | 210 | $3,369 | $16 |
| Potassium Chloride | 108 | $3,314 | $31 |
| Rosuvastatin | 65 | $2,577 | $40 |
| Diltiazem 24hr Er (Cd) | 60 | $2,448 | $41 |
| Valsartan | 29 | $2,423 | $84 |
| Flecainide Acetate | 21 | $2,280 | $109 |
| Atenolol | 186 | $2,049 | $11 |
| Diltiazem 24hr Er | 32 | $1,746 | $55 |
| Furosemide | 194 | $1,629 | $8 |
| Amiodarone | 39 | $1,629 | $42 |
| Clopidogrel | 82 | $1,560 | $19 |
| Metoprolol | 149 | $1,506 | $10 |
| Carvedilol | 105 | $1,493 | $14 |
| Lisinopril | 139 | $1,466 | $11 |
| Dilt-Xr | 31 | $1,456 | $47 |
| Amlodipine Besylate | 150 | $1,316 | $9 |
| Propafenone | 22 | $1,302 | $59 |
| Warfarin | 66 | $1,115 | $17 |
| Nitroglycerin | 61 | $945 | $15 |
| Irbesartan | 21 | $880 | $42 |
| Cartia Xt | 17 | $870 | $51 |
| Isosorbide Mononitrate Er | 50 | $855 | $17 |
| Levothyroxine | 27 | $842 | $31 |
| Digoxin | 16 | $671 | $42 |
| Pravastatin | 21 | $576 | $27 |
| Hydralazine | 17 | $480 | $28 |
| Fenofibrate | 14 | $450 | $32 |
| Pantoprazole | 24 | $413 | $17 |
| Tamsulosin | 15 | $366 | $24 |
| Hydrochlorothiazide | 70 | $343 | $5 |
| Clonidine | 23 | $266 | $12 |
| Metolazone | 11 | $258 | $23 |
| Triamterene-Hydrochlorothiazid | 14 | $164 | $12 |
| Metformin | 14 | $140 | $10 |
| Benazepril | 11 | $127 | $12 |
| Simvastatin | 21 | $117 | $6 |
2019: 46 drugs
| Xarelto | 220 | $220,796 | $1,004 |
| Eliquis | 139 | $135,020 | $971 |
| Entresto | 51 | $40,802 | $800 |
| Atorvastatin | 411 | $9,188 | $22 |
| Brilinta | 11 | $8,820 | $802 |
| Metoprolol | 201 | $6,679 | $33 |
| Rosuvastatin | 48 | $3,032 | $63 |
| Potassium Chloride | 82 | $2,972 | $36 |
| Losartan | 194 | $2,679 | $14 |
| Flecainide Acetate | 27 | $2,514 | $93 |
| Diltiazem 24hr Er (Cd) | 53 | $2,468 | $47 |
| Valsartan | 50 | $2,370 | $47 |
| Carvedilol | 132 | $2,130 | $16 |
| Atenolol | 162 | $1,969 | $12 |
| Lisinopril | 142 | $1,660 | $12 |
| Metoprolol | 170 | $1,616 | $10 |
| Dilt-Xr | 42 | $1,523 | $36 |
| Amlodipine Besylate | 139 | $1,496 | $11 |
| Furosemide | 153 | $1,466 | $10 |
| Clopidogrel | 77 | $1,411 | $18 |
| Ezetimibe | 18 | $1,382 | $77 |
| Bumetanide | 16 | $1,265 | $79 |
| Hydralazine | 37 | $1,261 | $34 |
| Warfarin | 85 | $1,255 | $15 |
| Propafenone | 19 | $1,176 | $62 |
| Amiodarone | 29 | $1,131 | $39 |
| Irbesartan | 32 | $963 | $30 |
| Nitroglycerin | 58 | $851 | $15 |
| Digoxin | 24 | $828 | $34 |
| Diltiazem 24hr Er | 27 | $821 | $30 |
| Isosorbide Mononitrate Er | 38 | $802 | $21 |
| Levothyroxine | 27 | $800 | $30 |
| Pravastatin | 24 | $797 | $33 |
| Cartia Xt | 18 | $466 | $26 |
| Pantoprazole | 24 | $455 | $19 |
| Hydrochlorothiazide | 66 | $446 | $7 |
| Tamsulosin | 18 | $436 | $24 |
| Simvastatin | 31 | $389 | $13 |
| Metformin | 26 | $326 | $13 |
| Finasteride | 13 | $245 | $19 |
| Quinapril | 11 | $200 | $18 |
| Benazepril | 12 | $189 | $16 |
| Spironolactone | 13 | $164 | $13 |
| Clonidine | 12 | $141 | $12 |
| Triamterene-Hydrochlorothiazid | 14 | $139 | $10 |
| Omeprazole | 11 | $111 | $10 |
2018: 42 drugs
| Xarelto | 165 | $147,786 | $896 |
| Eliquis | 144 | $123,726 | $859 |
| Entresto | 38 | $29,097 | $766 |
| Praluent | 11 | $12,491 | $1,136 |
| Brilinta | 27 | $11,744 | $435 |
| Atorvastatin | 344 | $8,164 | $24 |
| Ezetimibe | 18 | $5,282 | $293 |
| Metoprolol | 115 | $4,589 | $40 |
| Potassium Chloride | 60 | $3,011 | $50 |
| Rosuvastatin | 41 | $2,754 | $67 |
| Amiodarone | 46 | $2,418 | $53 |
| Warfarin | 97 | $2,161 | $22 |
| Lisinopril | 162 | $2,058 | $13 |
| Valsartan | 46 | $1,993 | $43 |
| Atenolol | 161 | $1,785 | $11 |
| Flecainide Acetate | 19 | $1,716 | $90 |
| Losartan | 142 | $1,643 | $12 |
| Clopidogrel | 70 | $1,607 | $23 |
| Digoxin | 36 | $1,573 | $44 |
| Carvedilol | 104 | $1,452 | $14 |
| Metoprolol | 176 | $1,435 | $8 |
| Furosemide | 140 | $1,280 | $9 |
| Amlodipine Besylate | 116 | $1,275 | $11 |
| Isosorbide Mononitrate Er | 39 | $1,085 | $28 |
| Levothyroxine | 28 | $1,047 | $37 |
| Nitroglycerin | 52 | $960 | $18 |
| Cartia Xt | 24 | $919 | $38 |
| Diltiazem 24hr Er (Cd) | 18 | $915 | $51 |
| Pravastatin | 27 | $915 | $34 |
| Dilt-Xr | 25 | $768 | $31 |
| Irbesartan | 34 | $739 | $22 |
| Propafenone | 15 | $657 | $44 |
| Hydralazine | 20 | $575 | $29 |
| Simvastatin | 41 | $526 | $13 |
| Pantoprazole | 28 | $441 | $16 |
| Benazepril | 21 | $383 | $18 |
| Tamsulosin | 13 | $364 | $28 |
| Metformin | 30 | $347 | $12 |
| Hydrochlorothiazide | 55 | $289 | $5 |
| Quinapril | 13 | $183 | $14 |
| Triamterene-Hydrochlorothiazid | 11 | $178 | $16 |
| Sotalol | 21 | $136 | $6 |
2017: 41 drugs
| Eliquis | 162 | $114,528 | $707 |
| Xarelto | 155 | $109,546 | $707 |
| Brilinta | 47 | $22,034 | $469 |
| Entresto | 20 | $12,410 | $621 |
| Atorvastatin | 317 | $7,217 | $23 |
| Potassium Chloride | 74 | $4,540 | $61 |
| Valsartan | 49 | $3,733 | $76 |
| Bystolic | 12 | $3,422 | $285 |
| Ezetimibe | 14 | $3,392 | $242 |
| Metoprolol | 75 | $3,029 | $40 |
| Amiodarone | 56 | $3,020 | $54 |
| Digoxin | 48 | $2,312 | $48 |
| Rosuvastatin | 28 | $2,205 | $79 |
| Losartan | 148 | $1,925 | $13 |
| Warfarin | 70 | $1,618 | $23 |
| Clopidogrel | 67 | $1,613 | $24 |
| Amlodipine Besylate | 98 | $1,587 | $16 |
| Atenolol | 137 | $1,554 | $11 |
| Pravastatin | 42 | $1,541 | $37 |
| Lisinopril | 158 | $1,508 | $10 |
| Carvedilol | 106 | $1,490 | $14 |
| Furosemide | 145 | $1,332 | $9 |
| Metoprolol | 153 | $1,322 | $9 |
| Diltiazem 24hr Er | 30 | $1,228 | $41 |
| Levothyroxine | 35 | $1,206 | $34 |
| Isosorbide Mononitrate Er | 27 | $1,004 | $37 |
| Cartia Xt | 25 | $832 | $33 |
| Simvastatin | 47 | $805 | $17 |
| Nitroglycerin | 39 | $756 | $19 |
| Hydralazine | 13 | $538 | $41 |
| Dilt-Xr | 18 | $535 | $30 |
| Metformin | 50 | $501 | $10 |
| Tamsulosin | 13 | $493 | $38 |
| Triamterene-Hydrochlorothiazid | 25 | $368 | $15 |
| Pantoprazole | 18 | $365 | $20 |
| Amlodipine Besylate-Benazepril | 15 | $230 | $15 |
| Quinapril | 16 | $215 | $13 |
| Hydrochlorothiazide | 39 | $214 | $5 |
| Benazepril | 13 | $196 | $15 |
| Sotalol | 20 | $117 | $6 |
| Glipizide | 11 | $106 | $10 |
2016: 45 drugs
| Eliquis | 167 | $95,311 | $571 |
| Xarelto | 101 | $66,573 | $659 |
| Effient | 18 | $10,519 | $584 |
| Zetia | 14 | $10,179 | $727 |
| Brilinta | 14 | $9,627 | $688 |
| Crestor | 18 | $9,293 | $516 |
| Entresto | 14 | $7,665 | $547 |
| Atorvastatin | 280 | $6,934 | $25 |
| Potassium Chloride | 93 | $4,862 | $52 |
| Valsartan | 31 | $3,952 | $127 |
| Amiodarone | 58 | $3,762 | $65 |
| Bystolic | 12 | $2,530 | $211 |
| Metoprolol | 69 | $2,509 | $36 |
| Warfarin | 101 | $2,437 | $24 |
| Digoxin | 54 | $2,186 | $40 |
| Carvedilol | 126 | $1,783 | $14 |
| Losartan | 137 | $1,706 | $12 |
| Pravastatin | 44 | $1,634 | $37 |
| Furosemide | 143 | $1,629 | $11 |
| Diltiazem 24hr Er | 38 | $1,588 | $42 |
| Lisinopril | 149 | $1,508 | $10 |
| Clopidogrel | 40 | $1,291 | $32 |
| Bumetanide | 12 | $1,255 | $105 |
| Atenolol | 155 | $1,143 | $7 |
| Simvastatin | 63 | $1,112 | $18 |
| Nitrostat | 40 | $1,090 | $27 |
| Metoprolol | 85 | $1,058 | $12 |
| Levothyroxine | 32 | $988 | $31 |
| Amlodipine Besylate | 98 | $947 | $10 |
| Diltiazem 24hr Cd | 12 | $926 | $77 |
| Isosorbide Mononitrate Er | 35 | $917 | $26 |
| Diltiazem Er | 14 | $706 | $50 |
| Propafenone | 17 | $674 | $40 |
| Dilt-Xr | 16 | $609 | $38 |
| Hydralazine | 13 | $599 | $46 |
| Digox | 16 | $579 | $36 |
| Tamsulosin | 15 | $576 | $38 |
| Metolazone | 13 | $394 | $30 |
| Metformin | 44 | $390 | $9 |
| Quinapril | 19 | $305 | $16 |
| Triamterene-Hydrochlorothiazid | 33 | $295 | $9 |
| Pantoprazole | 14 | $263 | $19 |
| Sotalol | 15 | $248 | $17 |
| Hydrochlorothiazide | 40 | $194 | $5 |
| Benazepril | 13 | $180 | $14 |
2015: 43 drugs
| Xarelto | 98 | $50,883 | $519 |
| Eliquis | 60 | $31,684 | $528 |
| Crestor | 38 | $13,872 | $365 |
| Atorvastatin | 249 | $6,544 | $26 |
| Effient | 13 | $6,452 | $496 |
| Brilinta | 18 | $6,267 | $348 |
| Amiodarone | 44 | $3,811 | $87 |
| Metoprolol | 86 | $3,743 | $44 |
| Potassium Chloride | 102 | $3,691 | $36 |
| Warfarin | 111 | $2,764 | $25 |
| Valsartan | 19 | $2,747 | $145 |
| Bystolic | 13 | $2,438 | $188 |
| Pravastatin | 51 | $2,392 | $47 |
| Digox | 41 | $2,326 | $57 |
| Carvedilol | 116 | $1,904 | $16 |
| Digoxin | 51 | $1,879 | $37 |
| Propafenone | 23 | $1,741 | $76 |
| Diltiazem 24hr Cd | 30 | $1,668 | $56 |
| Atenolol | 176 | $1,642 | $9 |
| Losartan | 132 | $1,601 | $12 |
| Lisinopril | 173 | $1,464 | $8 |
| Levothyroxine | 39 | $1,142 | $29 |
| Clopidogrel | 49 | $1,071 | $22 |
| Furosemide | 118 | $1,032 | $9 |
| Cartia Xt | 21 | $1,022 | $49 |
| Metoprolol | 105 | $1,009 | $10 |
| Simvastatin | 75 | $874 | $12 |
| Isosorbide Mononitrate Er | 42 | $794 | $19 |
| Digitek | 14 | $785 | $56 |
| Amlodipine Besylate | 84 | $736 | $9 |
| Nitrostat | 43 | $710 | $17 |
| Bumetanide | 15 | $703 | $47 |
| Tamsulosin | 16 | $648 | $41 |
| Diltiazem 24hr Er | 20 | $631 | $32 |
| Nitroglycerin Patch | 13 | $399 | $31 |
| Metformin | 42 | $334 | $8 |
| Meclizine | 11 | $276 | $25 |
| Sotalol | 17 | $269 | $16 |
| Hydrochlorothiazide | 40 | $218 | $5 |
| Hydralazine | 14 | $207 | $15 |
| Quinapril | 13 | $203 | $16 |
| Triamterene-Hydrochlorothiazid | 15 | $169 | $11 |
| Benazepril | 11 | $119 | $11 |
2014: 41 drugs
| Xarelto | 109 | $39,263 | $360 |
| Diovan | 33 | $13,004 | $394 |
| Crestor | 23 | $10,388 | $452 |
| Pradaxa | 13 | $10,246 | $788 |
| Eliquis | 21 | $7,440 | $354 |
| Atorvastatin | 213 | $5,917 | $28 |
| Benicar | 16 | $5,752 | $360 |
| Ranexa | 12 | $4,132 | $344 |
| Digox | 57 | $4,113 | $72 |
| Metoprolol | 84 | $4,096 | $49 |
| Clopidogrel | 67 | $2,718 | $41 |
| Potassium Chloride | 63 | $2,428 | $39 |
| Warfarin | 149 | $2,382 | $16 |
| Digoxin | 41 | $2,347 | $57 |
| Pravastatin | 40 | $2,061 | $52 |
| Carvedilol | 119 | $1,938 | $16 |
| Atenolol | 185 | $1,878 | $10 |
| Amiodarone | 30 | $1,556 | $52 |
| Propafenone | 31 | $1,504 | $49 |
| Simvastatin | 92 | $1,290 | $14 |
| Losartan | 76 | $1,271 | $17 |
| Lisinopril | 138 | $1,226 | $9 |
| Diltiazem Er | 19 | $1,018 | $54 |
| Diltiazem 24hr Er | 25 | $997 | $40 |
| Amlodipine Besylate | 91 | $907 | $10 |
| Furosemide | 102 | $761 | $7 |
| Levothyroxine | 30 | $746 | $25 |
| Klor-Con 10 | 13 | $697 | $54 |
| Diltiazem 24hr Cd | 12 | $688 | $57 |
| Metformin | 35 | $543 | $16 |
| Metoprolol | 51 | $469 | $9 |
| Isosorbide Mononitrate Er | 28 | $463 | $17 |
| Quinapril | 21 | $449 | $21 |
| Nitrostat | 25 | $338 | $14 |
| Hydrochlorothiazide | 50 | $269 | $5 |
| Zolpidem | 21 | $268 | $13 |
| Benazepril | 16 | $268 | $17 |
| Sotalol | 16 | $189 | $12 |
| Triamterene-Hydrochlorothiazid | 11 | $181 | $16 |
| Clonidine | 13 | $178 | $14 |
| Spironolactone | 11 | $90 | $8 |
2013: 43 drugs
| Diovan | 71 | $20,374 | $287 |
| Pradaxa | 35 | $15,150 | $433 |
| Crestor | 29 | $10,738 | $370 |
| Atorvastatin | 229 | $10,502 | $46 |
| Xarelto | 40 | $10,360 | $259 |
| Clopidogrel | 73 | $5,185 | $71 |
| Namenda | 15 | $4,479 | $299 |
| Metoprolol | 86 | $4,474 | $52 |
| Potassium Chloride | 75 | $3,079 | $41 |
| Warfarin | 142 | $2,885 | $20 |
| Eliquis | 11 | $2,815 | $256 |
| Carvedilol | 120 | $2,479 | $21 |
| Losartan | 65 | $2,070 | $32 |
| Diltiazem 24hr Er | 34 | $2,029 | $60 |
| Atenolol | 180 | $1,858 | $10 |
| Simvastatin | 104 | $1,699 | $16 |
| Lisinopril | 147 | $1,659 | $11 |
| Diltiazem Er | 28 | $1,594 | $57 |
| Amlodipine Besylate | 114 | $1,532 | $13 |
| Digox | 85 | $1,406 | $17 |
| Diltiazem 24hr Cd | 20 | $1,307 | $65 |
| Pravastatin | 32 | $1,156 | $36 |
| Klor-Con 10 | 14 | $945 | $67 |
| Furosemide | 117 | $922 | $8 |
| Propafenone | 16 | $795 | $50 |
| Levothyroxine | 42 | $739 | $18 |
| Metoprolol | 59 | $588 | $10 |
| Isosorbide Mononitrate Er | 17 | $560 | $33 |
| Nitrostat | 38 | $533 | $14 |
| Quinapril | 22 | $520 | $24 |
| Sotalol | 20 | $509 | $25 |
| Amiodarone | 33 | $505 | $15 |
| Clonidine | 32 | $423 | $13 |
| Metformin | 24 | $393 | $16 |
| Hydrochlorothiazide | 47 | $332 | $7 |
| Klor-Con M20 | 11 | $332 | $30 |
| Tamsulosin | 15 | $284 | $19 |
| Lovastatin | 14 | $254 | $18 |
| Digoxin | 17 | $228 | $13 |
| Zolpidem | 22 | $226 | $10 |
| Benazepril | 12 | $218 | $18 |
| Allopurinol | 12 | $155 | $13 |
| Irbesartan | 11 | $145 | $13 |
Money from drug and device companies
$348 in 2025
| 2025 | 7 | 9 | None | $348 |
| 2024 | 7 | 10 | None | $342 |
| 2023 | 4 | 7 | None | $414 |
| 2022 | 5 | 8 | None | $226 |
| 2021 | 5 | 10 | None | $300 |
| 2020 | 5 | 6 | None | $106 |
| 2019 | 6 | 19 | None | $1,432 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| CVRx | Barostim Neo System | $125 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $71 | 3 payments
|
| Abbott Laboratories | Aveir | $56 | 1 payment
|
| Stryker | Revcore Thrombectomy Catheter | $47 | 1 payment
|
| Biotronik | Amvia Edge | $21 | 1 payment
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $15 | 1 payment
|
See all 9 published payments
| Stryker | Meals · 2025-12-02 | Revcore Thrombectomy Catheter | $47 |
| CVRx | Meals · 2025-10-14 | Barostim Neo System | $125 |
| Philips North America | Meals · 2025-10-07 | Angio Ifr | $14 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-08-06 | Lifevest | $24 |
| Shockwave Medical | Meals · 2025-07-08 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $15 |
| Abbott Laboratories | Meals · 2025-06-12 | Aveir | $56 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-05-22 | Lifevest | $25 |
| Biotronik | Meals · 2025-05-21 | Amvia Edge | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-03-13 | Lifevest | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $342
| Boston Scientific | Watchman Flx | $133 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $60 | 2 payments
|
| Philips North America | (Bq9) Coronary Ivus | $42 | 2 payments
|
| Medtronic | Venaseal | $40 | 2 payments
|
| Cardiac Dimensions | None | $32 | 1 payment
|
| Novo Nordisk | Rybelsus | $19 | 1 payment
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $16 | 1 payment
|
2023: $414
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $184 | 2 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $153 | 1 payment
|
| Philips Electronics North America | (6585) Omniwire | $54 | 3 payments
|
| Medtronic | Micra | $22 | 1 payment
|
2022: $226
| AstraZeneca Pharmaceuticals LP | Brilinta | $100 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $61 | 4 payments
|
| Biotronik | Biomonitor | $28 | 1 payment
|
| Getinge USA Sales | Cardiosave Hybrid, Type B Plug | $22 | 1 payment
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $16 | 1 payment
|
2021: $300
| Abiomed | Impella | $119 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $99 | 1 payment
|
| Boston Scientific | Watchman | $29 | 1 payment
|
| Biotronik | Rivacor | $29 | 1 payment
|
| Abbott Laboratories | Optis Coronary Imaging System | $25 | 1 payment
|
2020: $106
| Biotronik | None | $29 | 2 payments
|
| Penumbra | Indigo | $24 | 1 payment
|
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $22 | 1 payment
|
| Boston Scientific | General - Brady | $16 | 1 payment
|
| Medtronic Vascular | Reveal Linq | $15 | 1 payment
|
2019: $1,432
| Abbott Laboratories | Xience V Coronary Stent System | $1,306 | 12 payments
|
| Boston Scientific | Vigilant | $68 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $18 | 2 payments
|
| Roche Diagnostics | Cd Cobas Reagents | $15 | 1 payment
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $13 | 1 payment
|
| Biotronik | None | $12 | 1 payment
|
Professional record
- NPI
- 1093797557
- Licence
- CA G54833California G54833: Current · expires 2027-01-31
- Trained
- University of Maryland School of Medicine, 1982
- Group
- Stanford Health Care · University Healthcare Alliance
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G548330
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 5565 W Las Positas Blvd Ste 150, Pleasanton, CA, 94588
- NPI first listed
- 2005-11-18
- NPI last updated
- 2024-04-22
- NPI record certified
- 2024-04-22
This is when the NPI record was last certified, not a medical board exam.